According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A that plays a crucial role in cellular differentiation and apoptosis. It is clinically proven for...

According to a newly published market research report by 24LifeSciences, global TB diagnostic market was valued at USD 2.57 billion in 2024 and is projected to reach USD 3.26 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.6% during the forecast period 2025–2031. Tuberculosis diagnostics encompass various medical tests and procedures including radiographic methods, nucleic acid amplification tests (NAATs), interferon-gamma release assays (IGRAs), culture-based...

According to a newly published market research report by 24LifeSciences, global immune checkpoint inhibitors market was valued at USD 42.6 billion in 2023 and is projected to reach USD 98.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2025-2032. Immune checkpoint inhibitors are monoclonal antibodies that block proteins used by cancer cells to evade immune detection, effectively "releasing the brakes" on T-cells to attack tumors. These...

According to a newly published market research report by 24LifeSciences, global cranial mesh market was valued at USD 472.8 million in 2024 and is projected to reach USD 682.4 million by 2032, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2024–2032. Cranial mesh, clinically known as cranial reconstruction implants, are critical medical devices widely used in neurosurgical procedures for traumatic brain injuries, tumor resections, and congenital...

According to a newly published market research report by 24LifeSciences, global adjunctive hemostats market was valued at USD 1.8 billion in 2023 and is projected to reach USD 2.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 20242030. Adjunctive hemostats are medical devices designed to control bleeding during surgical procedures when conventional methods prove insufficient. These critical products enhance the body's natural clotting...

How Healthcare CRO Partners Are Redefining Clinical Development in 2026 The role of a Healthcare CRO has expanded far beyond outsourced project support. Today, contract research organizations are becoming strategic partners for pharmaceutical companies, biotechnology firms, and medical device innovators seeking faster, smarter, and more compliant development pathways. As healthcare innovation accelerates, organizations increasingly depend on CRO expertise in clinical trials, patient...

Pharmaceutical Contract Manufacturing Is Reshaping Modern Drug Supply Chains Pharmaceutical Contract Manufacturing has become a core strategy for drug companies seeking faster launches, flexible capacity, and cost-efficient production. As therapies become more specialized and regulatory expectations rise, many pharmaceutical brands are relying on external experts for pharma outsourcing across development, scale-up, packaging, and commercial supply. This shift is no longer limited to large...

U.S. Pharmaceutical CDMO Growth Driven by Biologics, Fill Finish, and Smart Manufacturing The U.S. Pharmaceutical CDMO sector is becoming a strategic pillar of modern healthcare as drug developers seek faster launches, lower capital risk, and reliable domestic capacity. Contract development and manufacturing organizations now play a larger role in drug manufacturing, helping pharmaceutical and biotech companies move from formulation to commercial supply with greater efficiency. In...

Continuous Renal Replacement Therapy Advances Reshaping Critical Kidney Care Continuous Renal Replacement Therapy (CRRT) has become an essential component of modern intensive care medicine, especially for critically ill patients experiencing acute kidney injury, fluid overload, sepsis, or multi-organ dysfunction. Unlike conventional intermittent dialysis, CRRT delivers slower and continuous blood filtration over extended periods, making it more suitable for unstable patients in the ICU. As...

According to a newly published market research report by 24LifeSciences, global Hallux Abducto Valgus Correctors market was valued at USD 310 million in 2024 and is projected to reach USD 520 million by 2032, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2032. Hallux Abducto Valgus Correctors are non-surgical orthopedic devices designed to realign the big toe and correct bunion deformities. These medical-grade products typically consist of splints,...

According to a newly published market research report by 24LifeSciences, global mucopolysaccharide polysulphate market was valued at USD 175 million in 2025 and is projected to reach USD 285 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2026-2034. Mucopolysaccharide polysulphate (MPS), a sulfated glycosaminoglycan derivative, is a clinically significant compound with potent anti-inflammatory and cartilage-protective properties....

According to a newly published market research report by 24LifeSciences, global meropenem powder market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.1 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20262034. Meropenem, classified as a carbapenem antibiotic, represents a critical broad-spectrum antimicrobial agent primarily administered via intravenous infusion in hospital settings. Its mechanism of action...